Uri Weinberg, Chief Innovation Officer at NovoCure Ltd (NVCR), sold 268 shares at $18.92 ($5K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal sale ($5k) by Chief Innovation Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2025-03-03 | $168K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $946K | — | Filing → |
| NVCR | SELL | 2021-05-12 | $2.1M | — | Filing → |